PL3082845T3 - Sposoby i kompozycje do leczenia neuropatii obwodowych - Google Patents
Sposoby i kompozycje do leczenia neuropatii obwodowychInfo
- Publication number
- PL3082845T3 PL3082845T3 PL14872066T PL14872066T PL3082845T3 PL 3082845 T3 PL3082845 T3 PL 3082845T3 PL 14872066 T PL14872066 T PL 14872066T PL 14872066 T PL14872066 T PL 14872066T PL 3082845 T3 PL3082845 T3 PL 3082845T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- treatment
- methods
- peripheral neuropathies
- neuropathies
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 208000027232 peripheral nervous system disease Diseases 0.000 title 1
- 208000033808 peripheral neuropathy Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361919301P | 2013-12-20 | 2013-12-20 | |
| PCT/CA2014/051227 WO2015089664A1 (en) | 2013-12-20 | 2014-12-17 | Methods and compositions for treatment of peripheral neuropathies |
| EP14872066.7A EP3082845B1 (en) | 2013-12-20 | 2014-12-17 | Methods and compositions for treatment of peripheral neuropathies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3082845T3 true PL3082845T3 (pl) | 2021-08-02 |
Family
ID=53401865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14872066T PL3082845T3 (pl) | 2013-12-20 | 2014-12-17 | Sposoby i kompozycje do leczenia neuropatii obwodowych |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20170027957A1 (pl) |
| EP (2) | EP3082845B1 (pl) |
| CN (3) | CN106061497A (pl) |
| CA (1) | CA2934578A1 (pl) |
| ES (1) | ES2865624T3 (pl) |
| PL (1) | PL3082845T3 (pl) |
| WO (1) | WO2015089664A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019427489B2 (en) | 2019-01-28 | 2025-03-13 | Mitochondria Emotion, Inc. | Mitofusin activators and methods of use thereof |
| WO2020159797A1 (en) | 2019-01-28 | 2020-08-06 | Mitochondria Emotion, Inc. | Trans-4-hydroxycyclohexyl phenyl amide mitofusin activators and methods of use thereof |
| CA3133646A1 (en) * | 2019-03-26 | 2020-10-01 | Winsantor, Inc. | Topical formulations for treatment of peripheral neuropathies |
| SG10201907677QA (en) * | 2019-08-20 | 2021-03-30 | Yin Sze Loh | Formulations for use in the prevention and/or treatment of peripheral neuropathy and its associated diseases. |
| WO2021120937A1 (zh) * | 2019-12-17 | 2021-06-24 | 童妍(上海)医疗器械有限公司 | 转甲状腺素蛋白进入眼内以及在制备滴剂中的应用 |
| US11793754B1 (en) | 2022-06-16 | 2023-10-24 | King Abdulaziz University | Sodium hypochlorite and chlorhexidine based nanoemulsions and a method of preparation thereof |
| CN118647404A (zh) * | 2022-12-09 | 2024-09-13 | 荣昌生物制药(烟台)股份有限公司 | Cyp3a4/5诱导剂在治疗或缓解周围神经病变中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1147400A1 (ru) * | 1981-05-18 | 1985-03-30 | Научно-Исследовательский Институт Экспериментальной Медицины Амн Ссср | Способ лечени поражений периферических нервов |
| AU2006282896A1 (en) * | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| GB0602857D0 (en) * | 2006-02-13 | 2006-03-22 | Daniolabs Ltd | The treatment of sialorrhoea |
| ES2433568T3 (es) * | 2007-10-17 | 2013-12-11 | Curonz Holdings Company Limited | Análogos sintéticos de péptidos de regeneración neuronal |
| NO2632468T3 (pl) * | 2010-10-25 | 2018-05-12 | ||
| JP6133790B2 (ja) * | 2011-02-18 | 2017-05-24 | ザ スクリプス リサーチ インスティテュート | ミエリン形成細胞運命へのオリゴデンドロサイト前駆細胞の定方向分化 |
-
2014
- 2014-12-17 CA CA2934578A patent/CA2934578A1/en active Pending
- 2014-12-17 ES ES14872066T patent/ES2865624T3/es active Active
- 2014-12-17 CN CN201480075321.6A patent/CN106061497A/zh active Pending
- 2014-12-17 EP EP14872066.7A patent/EP3082845B1/en active Active
- 2014-12-17 US US15/106,778 patent/US20170027957A1/en not_active Abandoned
- 2014-12-17 EP EP21156057.8A patent/EP3895705A3/en active Pending
- 2014-12-17 WO PCT/CA2014/051227 patent/WO2015089664A1/en not_active Ceased
- 2014-12-17 PL PL14872066T patent/PL3082845T3/pl unknown
- 2014-12-17 CN CN202510216383.4A patent/CN120661657A/zh active Pending
- 2014-12-17 CN CN202011011663.5A patent/CN112057626A/zh active Pending
-
2021
- 2021-03-19 US US17/206,498 patent/US20210267998A1/en not_active Abandoned
-
2024
- 2024-04-26 US US18/647,336 patent/US20250090545A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2934578A1 (en) | 2015-06-25 |
| EP3895705A2 (en) | 2021-10-20 |
| ES2865624T3 (es) | 2021-10-15 |
| CN106061497A (zh) | 2016-10-26 |
| CN120661657A (zh) | 2025-09-19 |
| CN112057626A (zh) | 2020-12-11 |
| US20250090545A1 (en) | 2025-03-20 |
| US20210267998A1 (en) | 2021-09-02 |
| US20170027957A1 (en) | 2017-02-02 |
| EP3082845A1 (en) | 2016-10-26 |
| EP3082845B1 (en) | 2021-02-17 |
| WO2015089664A1 (en) | 2015-06-25 |
| EP3082845A4 (en) | 2017-10-25 |
| EP3895705A3 (en) | 2022-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273090B (en) | Methods and preparations for the treatment of cancer | |
| GB201320723D0 (en) | Composition and methods of treatment | |
| EP2958936A4 (en) | METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE | |
| SG11201601412XA (en) | Compositions and methods for the treatment of presbyopia | |
| IL239453A0 (en) | Preparations and methods for treating cancer using bacteria | |
| IL244089A0 (en) | Diagnostic methods and preparations for the treatment of glioblastoma | |
| IL238177A0 (en) | Methods and preparations for the treatment of cancer | |
| PT3021839T (pt) | Composições para o tratamento da fibrose | |
| IL239851B (en) | Methods and compositions for treating diseases that act to remove myelin | |
| ZA201408056B (en) | Compositions and methods for the treatment of mucositis | |
| ZA201408055B (en) | Compositions and methods for the treatment of local pain | |
| EP3082427A4 (en) | Compositions and methods for treatment of glaucoma | |
| PL3082845T3 (pl) | Sposoby i kompozycje do leczenia neuropatii obwodowych | |
| SG10201710538XA (en) | Compositions and methods for treating skin | |
| PL2968478T3 (pl) | Kompozycje i sposoby do leczenia karboksyhemoglobinemii | |
| EP3068431A4 (en) | Methods and compositions for the treatment of hcmv | |
| ZA201509360B (en) | Compositions and methods for treatment of stroke | |
| ZA201408065B (en) | Compositions and methods for the treatment of diabetes | |
| PL3079684T3 (pl) | Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna | |
| PT2992094T (pt) | Composições e métodos para tratamento de diabetes tipo 1 | |
| AU2013902004A0 (en) | Compositions for Therapy and Methods of Treatment | |
| GB201309001D0 (en) | Methods for prevention and treatment of preeclampsia |